The Food and Drug Administration (FDA) has approved the HIV-1 medication ibalizumab-uiyk (Trogarzo, Theratechnologies Inc) for administration by intravenous push. Ibalizumab-uiyk, a long-acting ...

This news release constitutes a “designated news release” for the purposes of the Company’s prospectus supplement dated December 16, 2021 to its short form base shelf prospectus dated December 14, ...

The new approval allows for the 2000mg loading dose to be administered as an IV push rather than a 30-minute IV infusion. The prescribing information for Trogarzo ® (ibalizumab-uiyk) has been updated ...

An RNA sequencing approach for isoform detection of DPEP1 in colorectal cancer and in vitro characterization of a novel isoform. This is an ASCO Meeting Abstract from the 2026 ASCO Annual Meeting I.

Pharma giants from Johnson & Johnson to Novartis to Roche, looking for edges in speed and convenience, have unveiled self-injection options to replace intravenous infusions in the fields of cancer, ...

Intravenous (IV) injection is a common route for medical treatment worldwide as it induces rapid effects and allows continuous administration of medication by directly injecting drugs into the blood ...